Try our Advanced Search for more refined results

Fee Bid In Bioscience Suit Deal Is Unfair, Chancery Told

By Rose Krebs (July 18, 2022, 3:07 PM EDT) -- A stockholder who has entered into a proposed settlement to end a Delaware Chancery Court suit over an allegedly unfair private offering that raised $70 million for Selecta Biosciences has asked the court to reject another investor's bid to also get attorney fees in connection with the deal....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!